Dashyant Dhanak

Twenty sales worth EUR 1,627,700, with a median of EUR 70,299: Dashyant Dhanak's sales are numerous but modest in size. The largest, EUR 302,431, is dated April 6, 2020; next come EUR 274,811 on June 10, 2021 and EUR 188,257 on January 26, 2023, all at Incyte Corp. No purchase is recorded.

The 57 filings were published between December 2018 and June 2024: 52 at Incyte and 5 at Deciphera Pharmaceuticals, Inc., under the title EVP & Chief Scientific Officer in both cases. The record also holds 24 grants and 12 option exercises.

The record is very concentrated: 22 filings in 2020 and 18 in 2021, against 1 to 7 in the other years. Dhanak's own market trades within 30 days of colleagues at Incyte Corp number 8, 8 and 8, every one in the same direction. In the same order, the colleagues are Barry P. Flannelly, Maria E. Pasquale and Vijay K. Iyengar.

The median publication delay is 2 days. No filing sits in the last twelve months.